Furthermore, CRY2 and PER2 would suppress glioma tumorigenesis by suppressing ETNK1 expression through the transcription factor NR4A2 or by suppressing C‐MYC or TP53 expression through the NPAS2‐BMAL1 complex (Figure 1B). This evidence concerns the gene PER2 and central nervous system cancer.